返回 
加入收藏
心血管慢病药品临床综合评价杭州专家共识
x
请在关注微信后，向客服人员索取文件
| 篇名： | 心血管慢病药品临床综合评价杭州专家共识 |
| TITLE： | CHINA PH ARMACY Volume 33，Number 9，May 15，2022 Semimonthly Table of Contents Hangzhou expert consensus on comprehensive clinical evaluation of drugs for chronic cardiovascular diseases |
| 摘要： | 心血管慢病防治药品品类繁多，但目前缺乏科学、规范的药品临床综合评价体系。为引导和推动相关医疗机构规范开展心血管慢病相关药品的临床综合评价，由浙江大学医学院附属杭州市第一人民医院牵头，联合杭州市药事管理质控中心及杭州市15家市属医疗机构共同参与，通过广泛征求临床和药学专家建议，制定了《心血管慢病药品临床综合评价杭州专家共识》，并以降压药品和调脂药品为例进行了试点评价。本专家共识的评价体系采用百分制量化评估，从药学特性、安全性、有效性、经济性、创新性、可及性、其他属性共7个维度进行系统评价，评价维度更加细化，增强了药品评价体系的可操作性，旨在为医疗机构心血管慢病药品的评价和遴选工作提供决策依据、促进合理用药，进而更高质量地满足人民群众的用药需求。 |
| ABSTRACT： | There are numerous dr ugs availabl e for the treatment and prevention of cardiovascular diseases. However ，the lack of scientific and standardized clinical comprehensive evaluation system for drugs is the current situation. In order to guide and promote medical institutions to develop the clinical comprehensive evaluation of drugs related to chronic cardiovascular diseases ， with the participation of Hangzhou Pharmacy Management Quality Control Center and 15 medical institutions in Hangzhou ，by widely soliciting the suggestions of clinical and pharmaceutical experts ，Hangzhou First People ’s Hospital Affiliated to the School of Medicine of Zhejiang University has organized the formulation of Hangzhou Expert Consensus on Comprehensive Clinical Evaluation of Drugs for Chronic Cardiovascular Diseases . The pilot evaluation is carried out with antihypertensive drugs and lipid-lowering drugs as examples. The evaluation system of expert consensus adopts a quantitative evaluation system of percentile ， which is systematically evaluated from 7 dimensions including pharmaceutical properties ，safety，effectiveness，economy， innovation，accessibility，and other attributes. The evaluation dimension is more detailed ，which enhances the operability of the drug evaluation system. The purpose of this expert consensus is to provide a decision-making basis for the evaluation and selection of drugs for chronic cardiovascular diseases in medical institutions ，to promote rational drug use and to meet people ’s growing need for better medications. |
| 期刊： | 2022年第33卷第09期 |
| 作者： | 杭州市药事管理质控中心药品评价专家组，浙江大学医学院附属杭州市第一人民医院 |
| AUTHORS： | Drug Evaluation Expert Group of Hangzhou Pharmaceutical Management Quality Control Center ；Affiliated Hangzhou First People ’s Hospital，Zhejiang University School of Medicine |
| 关键字： | 心血管慢病；药品临床综合评价；专家共识；降压药品；调脂药品 |
| KEYWORDS： | chronic cardiovascular diseases ；comprehensive clinical evaluation of drugs ；expert consensus ；antihypertensive |
| 阅读数： | 383 次 |
| 本月下载数： | 23 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
